Global Pharmacovigilance Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

Published Date : Aug 2019 | No. of Pages : 140 Pages | Category : Healthcare

The global pharmacovigilance market size is expected to reach USD 11.78 billion by 2026 and it is projected to expand at a CAGR of 13.3% during the forecast period 2019 to 2026.

Increasing incidence of Adverse Drug Reactions (ADR) is the key growth driver. The U.S. Food and Drug Administration (FDA) received approximately 253,017 serious adverse events and 44,693 deaths associated with ADRs in 2015. This shows the potential demand for implementing safety and Pharmacovigilance (PV) services.

Increasing acceptance and adoption of outsourcing services by healthcare companies will stimulate pharmacovigilance (PV) market growth in forthcoming years. Outsourcing eliminates the risk of business overhead costs as well as deployment of a pharmacovigilance resources. Outsourcing strategy increases the cost-effectiveness and efficiency by relieving resource pressure on firms. Positively shifting trends in PV outsourcing owing to increasing benefits will accelerate pharmacovigilance business growth in the coming years.

Rising number of adverse drug reactions (ADRs) will contribute to significant increase in the market size over the forecast period. According to National Centre for Biotechnology Information (NCBI), number of fatalities due to ADRs increased more than two-fold in 2014. This further led to increase in hospitalizations. Similarly, according to data by Clinics, 2018, there was 10.3% increase in ADR rate in Brazil per medication introduced during hospitalization. Such escalating number of ADRs that require continuous pharmacovigilance will render lucrative growth opportunity for pharmacovigilance market to facilitate effective surveillance of ADRs.

Accelerating demand for personalized medicines will impel momentous industry growth in the foreseeable future. Innovations in personalized medicine will offer growth potential to the market in ways to develop and quantitate risks and benefits of personalized medicines. Increasing advancement in targeted drugs such as new product development will further propel demand for pharmacovigilance services in the coming years.

Dearth of skilled healthcare professionals needed to analyse data and implement solutions can restrict market growth. Moreover, increased risk for data security that can be misused by the pharmacovigilance personnel can hamper business growth over the coming years.

Further key findings from the study suggest:

  • Phase IV held a dominant market share owing to the extensive post marketing surveillance of pharmaceuticals and increasing number of ADR incidences in the market
  • Phase III is anticipated to witness lucrative CAGR owing to increasing focus of pharmaceutical manufacturers on therapeutic development and safety monitoring
  • In service provider segment, contract outsourcing held a significant market share, owing to shift in focus of pharmaceutical companies to outsourcing services to reduce operational cost
  • Based on type of service, spontaneous reporting held the largest market share owing to its wide application in pharmacovigilance and benefits such as easy simulation of data sets for better drug comparison
  • Research organizations segment is anticipated to exhibit lucrative CAGR over the forecast period owing to increasing R&D for the development of novel biologics and medical devices
  • Asia Pacific pharmacovigilance market is anticipated to showcase lucrative CAGR in the forthcoming years
  • Industry participants are focusing on increasing R&D activities to develop better pharmacovigilance services.

The top players in this market are Clinquest Group B.V., Accenture, Plc, Cognizant Technology Solutions, iMED Global Corporation, Covance, Inc. ICON, Plc, inVentiv Health, Inc., Pharmaceutical Product Development LLC, Parexel International Corporation, PRA Health Sciences, Inc., F. Hoffmann-La Roche Ltd., Quintiles Transnational Holdings Inc, Sanofi , Wipro Limited, and Synowledge LLC, among others.

Segmentation:

Pharmacovigilance Clinical Trial Phase Outlook (Revenue, USD Million, 2015 - 2026)

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2015 - 2026)

  • In-house
  • Contract Outsourcing

Pharmacovigilance Type of Methods Outlook (Revenue, USD Million, 2015 - 2026)

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Pharmacovigilance End Use Outlook (Revenue, USD Million, 2015 - 2026)

  • Hospitals
  • Research Organizations
  • Industrial

Pharmacovigilance Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America
    • S.
    • Canada
  • Europe
    • K.
    • Germany
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Featured Research Reports

  • Featured Research Reports

    Global Tumor Ablation Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Minimally Invasive Surgical Instruments Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Biosurgery Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Dental Implants Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Cell Analysis Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...